MicroPort® Endoscopic Instrument Control System to Accomplish Robotic-assisted Surgery in Urology
NCT ID: NCT04404738
Last Updated: 2020-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
104 participants
INTERVENTIONAL
2020-06-29
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Robot-assisted Urological Surgeries Using the MicroHand S Robot
NCT05462392
Single-Port RAS Using Da Vinci SP Surgical System for UTUC Patients
NCT06987552
Exploring the Potential of Robotic Telesurgery in Remote Settings
NCT07130708
Improved Robotic-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Bladder Suspension and Preliminary Outcomes
NCT06977906
Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder.
NCT04966130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MicroPort® Surgical System
robot-assisted surgeries, for instance, prostatectomy, cystectomy or nephrectomy will be performed using MicroPort® surgical system
MicroPort® robot-assisted laparoscopic surgery
In this group, patients undergoing robot-assisted laparoscopic surgery in urology will be performed by Microport® Surgical System
da Vinci Surgical System
robot-assisted surgeries, for instance, prostatectomy, cystectomy or nephrectomy will be performed using da Vinci surgical system
da Vinci robot-assisted laparoscopic surgery
In this group, patients undergoing robot-assisted laparoscopic surgery in urology will be performed by da Vinci Surgical System
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MicroPort® robot-assisted laparoscopic surgery
In this group, patients undergoing robot-assisted laparoscopic surgery in urology will be performed by Microport® Surgical System
da Vinci robot-assisted laparoscopic surgery
In this group, patients undergoing robot-assisted laparoscopic surgery in urology will be performed by da Vinci Surgical System
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* laparoscopic surgery is required with one of the following surgical indications:(1)planning to perform radical prostatectomy(clinical stage is T1 or T2,and PSA≥ 0.2ng/mL) ;(2) planning to perform nephrectomy
* being able to cooperate and complete the follow-up and related examinations;
* volunteer to participate in this study and sign the informed consent.
Exclusion Criteria
* have severe cardiovascular or circulatory disease and cannot tolerate surgery;
* participated in other clinical trials in the last 3 months;
* failure to understand study requirements
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Changhai Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gao Xu
Chief Physician
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xu Gao, professor
Role: PRINCIPAL_INVESTIGATOR
Changhai Hospital
Jianming Guo, professor
Role: PRINCIPAL_INVESTIGATOR
Shanghai Zhongshan Hospital
Wei Xue, professor
Role: PRINCIPAL_INVESTIGATOR
RenJi Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine
Shanghai, , China
The first affiliated hospital of naval medical university (Shanghai changhai hospital)
Shanghai, , China
Zhongshan Hospital Affiliated to Fudan University
Shanghai, , China
Zhejiang Provincial People's Hospital
Zhejiang, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MPMB-2019-MKW
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.